Potassium channels: gene family, therapeutic relevance, high-throughput screening technologies and drug discovery.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Progress in drug research. Fortschritte der Arzneimittelforschung. Progres des recherches pharmaceutiques

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1007/978-3-0348-8183-8_4PMID 12079199
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Structure and complex transcription pattern of the mouse SK1 K(Ca) channel gene, KCNN1.

  2001cited by this paper
• Control of Electrical Activity in Central Neurons by Modulating the Gating of Small Conductance Ca2+-activated K+ Channels*

  2001cited by this paper
• The genomic basis of K(V)3.4 potassium channel mRNA diversity in mice.

  2001cited by this paper
• Structure of the gating domain of a Ca2+-activated K+ channel complexed with Ca2+/calmodulin

  2001cited by this paper
• Differential Expression of KCNQ2 Splice Variants: Implications to M Current Function during Neuronal Development

  2001cited by this paper
• Maxi-K Potassium Channels: Form, Function, and Modulation of a Class of Endogenous Regulators of Intracellular Calcium

  2001cited by this paper
• Activation of Expressed KCNQ Potassium Currents and Native Neuronal M-Type Potassium Currents by the Anti-Convulsant Drug Retigabine

  2001cited by this paper
• Characterization of KCNQ5/Q3 potassium channels expressed in mammalian cells

  2001cited by this paper
• HERG K+ channels: friend and foe.

  2001cited by this paper
• Recent developments in the biology and medicinal chemistry of potassium channel modulators: update from a decade of progress.

  2001cited by this paper
• Selective Blocking of Voltage-Gated K+ Channels Improves Experimental Autoimmune Encephalomyelitis and Inhibits T Cell Activation1

  2001cited by this paper
• MiRP2 forms potassium channels in skeletal muscle with Kv3.4 and is associated with periodic paralysis.

  2001cited by this paper
• Targeting acute ischemic stroke with a calcium-sensitive opener of maxi-K potassium channels

  2001cited by this paper
• Calmodulin binding to the C-terminus of the small-conductance Ca2+-activated K+ channel hSK1 is affected by alternative splicing.

  2001cited by this paper
• Alternative splicing of KCNQ2 potassium channel transcripts contributes to the functional diversity of M‐currents

  2001cited by this paper
• Regional expression of the splice variants of Kv4.3 in rat brain and effects of C-terminus deletion on expressed K+ currents.

  2001cited by this paper
• Inhibition by a novel anti-arrhythmic agent, NIP-142, of cloned human cardiac K+ channel Kv1.5 current.

  2001cited by this paper
• Design and SAR of novel potassium channel openers targeted for urge urinary incontinence. 2. Selective and potent benzylamino cyclobutenediones.

  2000cited by this paper
• Pharmacological and molecular analysis of ATP-sensitive K(+) channels in the pig and human detrusor.

  2000cited by this paper
• KCNQ5, a Novel Potassium Channel Broadly Expressed in Brain, Mediates M-type Currents*

  2000cited by this paper
• KCNQ4, a K+ channel mutated in a form of dominant deafness, is expressed in the inner ear and the central auditory pathway.

  2000cited by this paper
• Quantitative expression analysis of the small conductance calcium-activated potassium channels, SK1, SK2 and SK3, in human brain.

  2000cited by this paper
• A constitutively open potassium channel formed by KCNQ1 and KCNE3

  2000cited by this paper
• Design and SAR of novel potassium channel openers targeted for urge urinary incontinence. 1. N-Cyanoguanidine bioisosteres possessing in vivo bladder selectivity.

  2000cited by this paper
• Modulation of KCNQ2/3 potassium channels by the novel anticonvulsant retigabine.

  2000cited by this paper
• Potassium channels: molecular defects, diseases, and therapeutic opportunities.

  2000cited by this paper
• Novel approaches in diagnosis and therapy of Creutzfeldt-Jakob disease.

  2000cited by this paper
• Retigabine, a novel anti-convulsant, enhances activation of KCNQ2/Q3 potassium channels.

  2000cited by this paper
• G-protein mediated gating of inward-rectifier K+ channels.

  2000cited by this paper
• The TASK-1 Two-Pore Domain K+ Channel Is a Molecular Substrate for Neuronal Effects of Inhalation Anesthetics

  2000cited by this paper
• QT-interval prolongation by non-cardiac drugs: lessons to be learned from recent experience

  2000cited by this paper
• Chip based biosensor for functional analysis of single ion channels

  2000cited by this paper
• Effects of NS1608 on MaxiK Channels in Smooth Muscle Cells from Urinary Bladder

  2000cited by this paper
• Design of a potent and selective inhibitor of the intermediate-conductance Ca2+-activated K+ channel, IKCa1: a potential immunosuppressant.

  2000cited by this paper
• The Neuroprotective Agent Riluzole Activates the Two P Domain K+ Channels TREK-1 and TRAAK

  2000cited by this paper
• Internet resources for exploring gene family diversity.

  2000cited by this paper
• Involvement of G-protein-activated inwardly rectifying K (GIRK) channels in opioid-induced analgesia.

  2000cited by this paper
• Modulation of A-type potassium channels by a family of calcium sensors

  2000cited by this paper
• Drug discovery: a historical perspective.

  2000cited by this paper
• Differential expression of KvLQT1 isoforms across the human ventricular wall.

  2000cited by this paper
• Molecular basis for differential sensitivity of KCNQ and I(Ks) channels to the cognitive enhancer XE991.

  2000cited by this paper
• MiRP1 forms IKr potassium channels with HERG and is associated with cardiac arrhythmia.

  1999cited by this paper
• Inhibition of T cell proliferation by selective block of Ca2+-activated K+ channels

  1999cited by this paper
• Inhibition of T cell proliferation by selective block of Ca(2+)-activated K(+) channels.

  1999cited by this paper
• UK‐78,282, a novel piperidine compound that potently blocks the Kv1.3 voltage‐gated potassium channel and inhibits human T cell activation

  1999cited by this paper
• alpha subunit compositions of Kv1.1-containing K+ channel subtypes fractionated from rat brain using dendrotoxins.

  1999cited by this paper
• Ethanol opens G-protein-activated inwardly rectifying K+ channels

  1999cited by this paper
• Correolide and derivatives are novel immunosuppressants blocking the lymphocyte Kv1.3 potassium channels.

  1999cited by this paper
• An apamin-sensitive Ca2+-activated K+ current in hippocampal pyramidal neurons.

  1999cited by this paper
• Flupirtine shows functional NMDA receptor antagonism by enhancing Mg2+ block via activation of voltage independent potassium channels

  1999cited by this paper
• Prostaglandin E1 activates the large-conductance KCa channel in human corporal smooth muscle cells

  1999cited by this paper
• Different effects of tolbutamide and diazoxide in alpha, beta-, and delta-cells within intact islets of Langerhans.

  1999cited by this paper
• Subunit Composition of Kv1 Channels in Human CNS

  1999cited by this paper
• Synergistic Activation of G Protein–Gated Inwardly Rectifying Potassium Channels by the βγ Subunits of G Proteins and Na+ and Mg2+ Ions

  1999cited by this paper
• Pharmacological management of diabetes: recent progress and future perspective in daily drug treatment.

  1999cited by this paper
• Cell-based assays and instrumentation for screening ion-channel targets.

  1999cited by this paper
• Comparison of the potassium channel openers, WAY-133537, ZD6169, and celikalim on isolated bladder tissue and In vivo bladder instability in rat.

  1999cited by this paper
• Inhalational anesthetics activate two-pore-domain background K+ channels

  1999cited by this paper
• Pharmacology of voltage-gated and calcium-activated potassium channels.

  1999cited by this paper
• Functional analysis of native and recombinant ion channels using a high-capacity nonradioactive rubidium efflux assay.

  1999cited by this paper
• Genomic structure of three long QT syndrome genes: KVLQT1, HERG, and KCNE1.

  1998cited by this paper
• General principles of the structure of ion channels.

  1998cited by this paper
• ATP-sensitive K+ channels in pancreatic, cardiac, and vascular smooth muscle cells.

  1998cited by this paper
• KCNQ2 and KCNQ3 potassium channel subunits: molecular correlates of the M-channel.

  1998cited by this paper
• Pharmacological intervention in age-associated brain disorders by Flupirtine: Alzheimer's and prion diseases.

  1998cited by this paper
• Distinct functional stoichiometry of potassium channel beta subunits.

  1998cited by this paper
• Voltage-Gated Ion Channels Review and Electrical Excitability

  1998cited by this paper
• Formation of intermediate-conductance calcium-activated potassium channels by interaction of Slack and Slo subunits

  1998cited by this paper
• Two new potent neurotransmitter release enhancers, 10,10-bis(4-pyridinylmethyl)-9(10H)-anthracenone and 10,10-bis(2-fluoro-4-pyridinylmethyl)-9(10H)-anthracenone: comparison to linopirdine.

  1998cited by this paper
• Intracorporal injection of hSlo cDNA in rats produces physiologically relevant alterations in penile function.

  1998cited by this paper
• ATP-sensitive potassium channels: structures, functions, and pathophysiology.

  1998cited by this paper
• Neurobiology of the Caenorhabditis elegans genome.

  1998cited by this paper
• Inhibition of M-type K+ current by linopirdine, a neurotransmitter-release enhancer, in NG108-15 neuronal cells and rat cerebral neurons in culture.

  1998cited by this paper
• ATP-sensitive K+ channels in pancreatic, cardiac, and vascular smooth muscle cells.

  1998cited by this paper
• Distinct functional stoichiometry of potassium channel β subunits

  1998cited by this paper
• Direct activation of inward rectifier potassium channels by PIP2 and its stabilization by Gβγ

  1998cited by this paper
• New Modulatory α Subunits for Mammalian ShabK+ Channels*

  1997cited by this paper
• Antisense oligodeoxynucleotides directed against Kv1.5 mRNA specifically inhibit ultrarapid delayed rectifier K+ current in cultured adult human atrial myocytes.

  1997cited by this paper
• Effects of the K+ channel opener, ZD6169, on volume and PGE2-stimulated bladder activity in conscious rats.

  1997cited by this paper
• Cloning and characterization of Kir3.1 (GIRK1) C-terminal alternative splice variants.

  1997cited by this paper
• Expression of sulphonylurea receptors in bovine monocytes from animals with a different metabolic rate

  1997cited by this paper
• Linopirdine: Pharmacology of a Neurotransmitter Release Enhancer

  1997cited by this paper
• Blockade of the voltage-gated potassium channel Kv1.3 inhibits immune responses in vivo.

  1997cited by this paper
• Influence of flupirtine on a G‐protein coupled inwardly rectifying potassium current in hippocampal neurones

  1997cited by this paper
• Class III antiarrhythmic activity in vivo by selective blockade of the slowly activating cardiac delayed rectifier potassium current IKs by (R)-2-(2,4-trifluoromethyl)-N-[2-oxo-5-phenyl-1-(2,2,2-trifluoroethyl)- 2, 3-dihydro-1H-benzo[e][1,4]diazepin-3-yl]acetamide.

  1997cited by this paper
• Cloned potassium channels from eukaryotes and prokaryotes.

  1997cited by this paper
• Ion channels in the immune system as targets for immunosuppression.

  1997cited by this paper
• Determinants of Apamin and d-Tubocurarine Block in SK Potassium Channels*

  1997cited by this paper
• A new wave for heart rhythms

  1996cited by this paper
• Evidence for two components of delayed rectifier K+ current in human ventricular myocytes.

  1996cited by this paper
• Therapy with oral clotrimazole induces inhibition of the Gardos channel and reduction of erythrocyte dehydration in patients with sickle cell disease.

  1996cited by this paper
• Phenotypic Alteration of a Human BK (hSlo) Channel byhSloβ Subunit Coexpression: Changes in Blocker Sensitivity, Activation/Relaxation and Inactivation Kinetics, and Protein Kinase A Modulation

  1996cited by this paper
• Novel nonpeptide agents potently block the C-type inactivated conformation of Kv1.3 and suppress T cell activation.

  1996cited by this paper
• Comparison of Binding and Block Produced by Alternatively Spliced Kvβ1 Subunits*

  1996cited by this paper
• Heteromultimerization of G-Protein-Gated Inwardly Rectifying K+ Channel Proteins GIRK1 and GIRK2 and Their Altered Expression in weaver Brain

  1996cited by this paper
• Discrimination between subtypes of apamin‐sensitive Ca2+‐ activated K+ channels by gallamine and a novel bis‐quaternary quinolinium cyclophane, UCL 1530

  1996cited by this paper
• KvLQT1 and IsK (minK) proteins associate to form the IKS cardiac potassium current

  1996cited by this paper
• Comparison of binding and block produced by alternatively spliced Kvbeta1 subunits.

  1996cited by this paper
• Coassembly of KVLQT1 and minK (IsK) proteins to form cardiac IKS potassium channel

  1996cited by this paper
• Coassembly of K(V)LQT1 and minK (IsK) proteins to form cardiac I(Ks) potassium channel.

  1996cited by this paper

• Medicinal Chemistry of Potassium Channel Modulators: An update of Recent Progress (2011-2017).

  2019cites this paper
• Ion channels as therapeutic targets: a drug discovery perspective.

  2013cites this paper
• SKCa Channels Blockage Increases the Expression of Adenosine A2A Receptor in Jurkat Human T Cells

  2013cites this paper
• Thiéno- et furo- pyrimidines et pyridines, convenant comme inhibiteurs du canal potassium

  2012cites this paper
• The Endothelium, Part I: Multiple Functions of the Endothelial Cells -- Focus on Endothelium-Derived Vasoactive Mediators

  2011cites this paper
• The Endothelium, Part II: EDHF-Mediated Responses "The Classical Pathway"

  2011cites this paper
• Effects of Androgens in the Onset and Magnitude of Salt- Induced Hypertension in Male Sprague-Dawley Rats

  2010cites this paper
• Potassium channels in the basal ganglia: promising new targets for the treatment of Parkinson's disease.

  2008cites this paper
• Classification of voltage-gated K(+) ion channels from 3D pseudo-folding graph representation of protein sequences using genetic algorithm-optimized support vector machines.

  2008cites this paper
• Chronic Inhibition of Cardiac Kir2.1 and hERG Potassium Channels by Celastrol with Dual Effects on Both Ion Conductivity and Protein Trafficking*♦

  2006cites this paper
• Role of potassium in regulating blood flow and blood pressure.

  2006cites this paper
• Molecular Mechanisms Linking Salt to Hypertension Role of potassium in regulating blood flow and blood pressure

  2006cites this paper
• QT prolongation through hERG K+ channel blockade: Current knowledge and strategies for the early prediction during drug development

  2005cites this paper
• Addendum: Spider toxins and their potential for insect control

  2005cites this paper
• Computational identification of residues that modulate voltage sensitivity of voltage-gated potassium channels

  2005cites this paper
• Multiplexed G-Protein–Coupled Receptor Ca₂+ Flux Assays for High-Throughput Screening

  2005cites this paper
• A Thallium-Sensitive, Fluorescence-Based Assay for Detecting and Characterizing Potassium Channel Modulators in Mammalian Cells

  2004cites this paper
• Novel aspects of signaling and ion-homeostasis regulation in immunocytes. The TRPM ion channels and their potential role in modulating the immune response.

  2004cites this paper
• Rapid and efficient identification of cysteine-rich peptides by random screening of a venom gland cDNA library from the hexathelid spider Macrothele gigas.

  2004cites this paper
• KATP channel openers: Structure‐activity relationships and therapeutic potential

  2004cites this paper
• High-throughput technologies for studying potassium channels - Progresses and challenges

  2004cites this paper
• Phylogenomic analysis and evolution of the potassium channel gene family.

  2003cites this paper
• The therapeutic potential of neuronal KCNQ channel modulators

  2003cites this paper
• Distinct primary structures of the major peptide toxins from the venom of the spider Macrothele gigas that bind to sites 3 and 4 in the sodium channel1

  2003cites this paper